Drug Shortage Report for MULTI 12 INJECTION

Last updated on 2019-12-24 History
Report ID 100121
Drug Identification Number 02100606
Brand name MULTI 12 INJECTION
Common or Proper name MULTI-12
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VITAMIN B1 VITAMIN B2 BIOTIN FOLIC ACID DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN C VITAMIN E VITAMIN D VITAMIN A VITAMIN B12
Strength(s) 0.6MG 0.72MG 12MCG 80MCG 3MG 0.8MG 8MG 20MG 2UNIT 40UNIT 660UNIT 1MCG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10 Vials
ATC code B05XC
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-12-02
Estimated end date 2019-12-18
Actual end date 2019-12-23
Shortage status Resolved
Updated date 2019-12-24
Company comments Limited supply at Baxter - On allocation at 100% of historical usage
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-12-24 English Compare
v4 2019-12-23 French Compare
v3 2019-12-23 English Compare
v2 2019-12-03 French Compare
v1 2019-12-03 English Compare

Showing 1 to 5 of 5